- Home
- ALDX vs MG Comparison
ALDX vs MG Comparison
Compare ALDX & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- MG
- Stock Information
- Founded
- ALDX 2004
- MG 1978
- Country
- ALDX United States
- MG United States
- Employees
- ALDX N/A
- MG N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- MG Military/Government/Technical
- Sector
- ALDX Health Care
- MG Consumer Discretionary
- Exchange
- ALDX Nasdaq
- MG Nasdaq
- Market Cap
- ALDX 160.8M
- MG 236.5M
- IPO Year
- ALDX 2014
- MG 2009
- Fundamental
- Price
- ALDX $4.30
- MG $8.15
- Analyst Decision
- ALDX Strong Buy
- MG
- Analyst Count
- ALDX 2
- MG 0
- Target Price
- ALDX $9.50
- MG N/A
- AVG Volume (30 Days)
- ALDX 1.0M
- MG 172.0K
- Earning Date
- ALDX 07-31-2025
- MG 07-30-2025
- Dividend Yield
- ALDX N/A
- MG N/A
- EPS Growth
- ALDX N/A
- MG N/A
- EPS
- ALDX N/A
- MG 0.47
- Revenue
- ALDX N/A
- MG $706,813,000.00
- Revenue This Year
- ALDX N/A
- MG $0.81
- Revenue Next Year
- ALDX N/A
- MG $2.93
- P/E Ratio
- ALDX N/A
- MG $17.24
- Revenue Growth
- ALDX N/A
- MG N/A
- 52 Week Low
- ALDX $1.14
- MG $7.06
- 52 Week High
- ALDX $7.20
- MG $12.44
- Technical
- Relative Strength Index (RSI)
- ALDX 78.08
- MG 58.59
- Support Level
- ALDX $3.68
- MG $7.47
- Resistance Level
- ALDX $4.21
- MG $8.13
- Average True Range (ATR)
- ALDX 0.28
- MG 0.20
- MACD
- ALDX 0.10
- MG 0.08
- Stochastic Oscillator
- ALDX 93.48
- MG 93.90
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.